Standard laparoscopy remains the routine approach to cholecystectomy

Surgery ◽  
2021 ◽  
Author(s):  
James J. Jung ◽  
Denise W. Gee
Keyword(s):  
2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Riccardo Autorino ◽  
Rafael Sanchez-Salas ◽  
Octavio Castillo ◽  
Antonio Celia ◽  
Xavier Chatelineau ◽  
...  

Author(s):  
Meenakshi Yeola ◽  
Dilip Gode ◽  
Akshay Bora

AbstractThe field of laparoscopic surgery has experienced tremendous growth in the last three decades. The important events among them have been the invention of incandescent bulbs by Thomas Edison, the development of lens scopes (1870–1980s), the invention of rod lens system by Hopkins (1950s), the fiberoptic cold light transmission (1960s), and the computer chip video camera (1980s).Technological advancements have produced progressively smaller laparoscopic instruments and higher quality imaging that allow laparoscopic surgeons to perform precise dissection with minimal bleeding through most dissection planes, and the major limitations of standard laparoscopy procedures are overcome with these advances.The introduction and evolution of minimally invasive surgery has drastically changed the entire scenario of the ways in which surgeons are treating the patients. With the introduction of various innovative technologies like high-definition television, video systems, integrated digital reporting, head-mounted displays, surgical robotics, virtual reality training, and the integration of various modalities, such as ultrasound, computed tomography, and magnetic resonance imaging, the surgeon has better knowledge of the disease, thereby, treating the patient more effectively.In this review article, we explore the evolution of laparoscopy through the ages, thereby, making way for further development in the field of minimal access surgery.


2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 212-212
Author(s):  
Cristiina A. Metildi ◽  
Sharmeela Kaushal ◽  
Hop S. Tran Cao ◽  
Cynthia S. Snyder ◽  
Mark A. Talamini ◽  
...  

212 Background: Standard laparoscopy for pancreatic cancer often leads to false negative results, causing understaging of the disease. Improved sensitivity and resolution are necessary. Methods: Orthotopic and carcinomatosis mouse models of human pancreatic cancer were established with red fluorescent protein (RFP)-expressing or non-fluorescent BxPC-3 human pancreatic cancer cells. The mice with orthotopic unlabeled pancreatic cancer were administered Alexa 488- or 555-conjugated anti-CEA by tail-vein injection 2-4 weeks after tumor implantation. Diagnostic laparoscopy was performed with a Stryker L9000 LED light source or X8000 xenon light source 24 hours later. Pancreatic tumors were detected and localized under each light mode. After laparoscopy, intravital images were obtained with the OV-100 and Maestro CRI Small Animal Imaging Systems as positive controls. Tumors were collected for histologic analysis. Results: Fluorescence laparoscopy (FL) with the use of 495-nm excitation filter and an LED light source enabled more rapid and accurate identification and localization of primary tumors and metastases than bright light laparoscopy (BL). The use of fluorescent conjugates antibody-labeled tumors improved the accuracy of staging laparoscopy, increasing the sensitivity from 40% in BL to 96% in FL (p<0.001). FL was sufficiently sensitive to detect sub-millimeter tumor deposits that went undetected under BL. With adjustments to the LED light source, we could simultaneously detect tumor lesions of different fluorescent colors and surrounding structures with minimal autofluorescence. Conclusions: The use of FL and fluorophore-labeled anti-CEA antibodies permits rapid detection and accurate localization of primary and metastatic CEA-expressing human pancreatic cancer, including tumors that were undetectable with BL. The introduction of an LED light source allows simultaneous identification of fluorescent tumor of different wavelengths without compromising background illumination. Further development of this technology for clinical use can improve the staging and treatment of pancreatic cancer.


2008 ◽  
Vol 111 (3) ◽  
pp. 407-411 ◽  
Author(s):  
Maria C. Bell ◽  
Jenny Torgerson ◽  
Usha Seshadri-Kreaden ◽  
Allison Wierda Suttle ◽  
Sharon Hunt

2000 ◽  
Vol 9 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Lynn Burmeister ◽  
Jim Tsaltas ◽  
Andrew Griffiths ◽  
Colin Goodchild ◽  
Pam Mamers ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document